Engineering Longevity with AI
AI-powered longevity engineering for the next generation of regenerative medicine.
COMPANY OVERVIEW
We are an AI-native biomedicine company building a dry-lab, GPU-accelerated discovery platform for longevity- and youthfulness-oriented regenerative biologics.
Our platform leverages perinatal biology–derived reference datasets and AI-driven modeling to identify youthful regenerative signaling pathways associated with healthy longevity, and to computationally prioritize biologic candidates informed by youthful biological states.
The company is focused on computational discovery and candidate prioritization for longevity-relevant regenerative biology, with long-term translation into engineered biologics advanced through standard IND development pathways.
AI LONGEVITY INFRASTRUCTURE & TECHNOLOGY ALIGNMENT
EonVita is building an AI-native longevity discovery platform architected around clearly defined GPU-accelerated deep learning workflows for high-dimensional biological systems modeling.
Core Modeling
• Graph Neural Networks (GNNs) for biological pathway inference
• Transformer-based multi-omics embeddings
• Systems-level regenerative signaling network modeling
Data & Compute Architecture
• Integration of genomic, proteomic, and metabolic datasets
• PyTorch-based model development with CUDA-enabled GPU acceleration
• Scalable distributed GPU training environments
Compute Scaling Roadmap
Phase 1 – Prototype biological modeling
Phase 2 – GPU-accelerated multi-omics optimization
Phase 3 – Distributed multi-GPU systems-level scaling
EonVita’s computational architecture is intentionally aligned with NVIDIA’s accelerated computing ecosystem to support scalable biological modeling, performance optimization, and long-term platform growth.
TEAM STRUCTURE
Our founding team combines scientific leadership in regenerative biology with business and platform development expertise focused on longevity-oriented discovery.
The team brings experience across law, finance, and structured venture development, supporting disciplined execution, governance clarity, and long-term platform strategy.
AI engineering and computational biology resources are structured to be employed to scale in alignment with platform development milestones as modeling transitions from architecture to active biological inference and candidate optimization.
A designated technical lead will oversee GPU-accelerated model development and deployment.
A founding team member held an individual NVIDIA ecosystem membership prior to the formal incorporation of EonVita Biosciences.